Cardiac myosin activator

This page covers all Cardiac myosin activator drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Cardiac myosin.

Targets

Cardiac myosin

Phase 3 pipeline (1)

• Omecamtiv Mecarbil (OM) · Cytokinetics · Cardiovascular
  Omecamtiv mecarbil is a cardiac myosin activator that directly enhances the force of heart muscle contraction by increasing the number of myosin heads that generate force during systole.